We have developed a combination drug-device that will reduce cell injury after restoration of blood flow. This technology brings together a clinically proven drug with a new drug delivery technology. This helps patients recover faster following loss of blood flow. Our technology allows patients to get back on their feet faster with less disability.
BETTER PATIENT OUTCOMES
REDUCES FUTURE COSTS
WHAT COMES NEXT
Currently in the research and development stage, Downstream is seeking funding to finish research and development and the first phase of testing on our road to FDA approval. Please get in touch with our team if you are interested in joining us.